• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病快速进展患者的神经心理学预测因子。

Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease.

机构信息

Fondazione Santa Lucia IRCCS, Rome, Italy.

出版信息

Dement Geriatr Cogn Disord. 2010;30(3):219-28. doi: 10.1159/000319533. Epub 2010 Sep 14.

DOI:10.1159/000319533
PMID:20838048
Abstract

BACKGROUND

Alzheimer disease (AD) has heterogeneous clinical manifestations. Different neuropsychological profiles in AD patients might be indicative of the diffusion of the pathological process and might be associated with differences in rates of disease progression.

METHODS

We studied 154 newly diagnosed AD patients (65.6% women; mean age: 73 years). Performance in memory, executive functions, praxis and language domains was categorized into mild, moderate and severe impairment. The time-dependent probability of losing 5 points on the Mini-Mental State Examination (MMSE) over 2 years was considered as disease progression and evaluated by survival analysis.

RESULTS

One fourth of the patients decreased by ≥ 5 MMSE points over the 2-year follow-up. Rapid disease progression was more frequent in more educated patients and in those with moderate severity of global cognitive impairment. In univariate analysis, more severe memory and executive functioning impairment were associated with higher probabilities of progression. The association with memory was explained by differences in executive function impairment that remained statistically significant in multivariate analyses.

CONCLUSIONS

Patients with more severe executive functioning impairment have a worse prognosis over 2 years. This might be due to involvement of the prefrontal cortex by the pathological process of AD in patients with severe executive deficits.

摘要

背景

阿尔茨海默病(AD)具有异质性的临床表现。AD 患者不同的神经心理学特征可能表明病理过程的扩散,并可能与疾病进展速度的差异有关。

方法

我们研究了 154 名新诊断的 AD 患者(65.6%为女性;平均年龄:73 岁)。将记忆、执行功能、实践和语言领域的表现分为轻度、中度和重度损伤。将 2 年内 Mini-Mental State Examination(MMSE)减少 5 分的时间依赖性概率视为疾病进展,并通过生存分析进行评估。

结果

四分之一的患者在 2 年的随访中 MMSE 评分下降≥5 分。受教育程度较高的患者和认知障碍程度中度的患者更易出现快速疾病进展。在单因素分析中,更严重的记忆和执行功能障碍与更高的进展概率相关。与记忆的关联可由执行功能障碍的差异解释,在多变量分析中仍具有统计学意义。

结论

执行功能障碍更严重的患者在 2 年内的预后更差。这可能是由于 AD 病理过程累及前额叶皮层,导致执行功能严重受损的患者出现这种情况。

相似文献

1
Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease.阿尔茨海默病快速进展患者的神经心理学预测因子。
Dement Geriatr Cogn Disord. 2010;30(3):219-28. doi: 10.1159/000319533. Epub 2010 Sep 14.
2
Working memory in early Alzheimer's disease: a neuropsychological review.早期阿尔茨海默病的工作记忆:神经心理学综述。
Int J Geriatr Psychiatry. 2010 Feb;25(2):121-32. doi: 10.1002/gps.2314.
3
Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.预测阿尔茨海默病的疾病进展:神经精神综合征对功能和认知下降的作用。
J Alzheimers Dis. 2011;24(1):35-45. doi: 10.3233/JAD-2010-101836.
4
Neuropsychological predictors of dependency in patients with Alzheimer disease.阿尔茨海默病患者依赖的神经心理学预测因素
Neurology. 2005 Mar 22;64(6):1027-31. doi: 10.1212/01.WNL.0000154529.53488.30.
5
Cognitive profiles of incipient dementia in the Goteborg MCI study.哥德堡轻度认知损伤研究中初期痴呆的认知特征。
Dement Geriatr Cogn Disord. 2010;30(5):403-10. doi: 10.1159/000321352. Epub 2010 Oct 23.
6
Predictors of progression from mild cognitive impairment to Alzheimer disease.从轻度认知障碍进展为阿尔茨海默病的预测因素。
Neurology. 2007 May 8;68(19):1596-602. doi: 10.1212/01.wnl.0000260968.92345.3f.
7
Dual-task performance in Alzheimer's disease, mild cognitive impairment, and normal ageing.阿尔茨海默病、轻度认知障碍和正常衰老中的双重任务表现。
Arch Clin Neuropsychol. 2011 Jun;26(4):340-8. doi: 10.1093/arclin/acr032. Epub 2011 May 15.
8
Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).对接受乙酰胆碱酯酶抑制剂(AChEl)治疗的阿尔茨海默病(AD)患者认知障碍和残疾程度斜率的评估。
Arch Gerontol Geriatr. 2007;44 Suppl 1:91-6. doi: 10.1016/j.archger.2007.01.013.
9
New developments in the treatment of Alzheimer's disease.阿尔茨海默病治疗的新进展。
J Clin Psychiatry. 2009 Feb;70(2):281-90.
10
Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.中国东北地区帕金森病患者的认知恶化速度。
Dement Geriatr Cogn Disord. 2010;30(1):64-70. doi: 10.1159/000314682. Epub 2010 Aug 5.

引用本文的文献

1
Dopamine System Dysfunction in Alzheimer's Disease.阿尔茨海默病中的多巴胺系统功能障碍
Psychogeriatrics. 2025 Sep;25(5):e70097. doi: 10.1111/psyg.70097.
2
The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.临床诊断为阿尔茨海默病的快速认知能力下降的病理学。
J Alzheimers Dis. 2019;70(4):983-993. doi: 10.3233/JAD-190302.
3
Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.阿尔茨海默病神经精神症状的危险因素、神经解剖学关联及转归
J Alzheimers Dis. 2017;60(2):483-493. doi: 10.3233/JAD-160767.
4
The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.阿尔茨海默病的进展:快速衰退者真的衰退得快吗?一项四年随访研究
J Alzheimers Dis. 2017;57(3):775-786. doi: 10.3233/JAD-161264.
5
Demographic and clinical characteristics related to cognitive decline in Alzheimer disease in China: A multicenter survey from 2011 to 2014.中国阿尔茨海默病认知功能减退相关的人口统计学和临床特征:一项2011年至2014年的多中心调查
Medicine (Baltimore). 2016 Jun;95(26):e3727. doi: 10.1097/MD.0000000000003727.
6
Rapidly Versus Slowly Progressing Patients With Alzheimer's Disease: Differences in Baseline Cognition.阿尔茨海默病快速进展与缓慢进展患者:基线认知差异
Am J Alzheimers Dis Other Demen. 2016 Jun;31(4):318-25. doi: 10.1177/1533317515617720. Epub 2015 Dec 8.
7
The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.阿尔茨海默病的进展可用简短版CERAD神经心理成套测验进行评估:库奥皮奥ALSOVA研究
Dement Geriatr Cogn Dis Extra. 2014 Dec 11;4(3):494-508. doi: 10.1159/000369159. eCollection 2014 Sep-Dec.
8
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.脑炎症是阿尔茨海默病患者早逝的潜在机制:一项长达 13 年的特定病因多变量死亡率研究。
Alzheimers Res Ther. 2014 Jul 7;6(4):41. doi: 10.1186/alzrt271. eCollection 2014.
9
"Is dopamine involved in Alzheimer's disease?".多巴胺与阿尔茨海默病有关吗?
Front Aging Neurosci. 2014 Sep 25;6:252. doi: 10.3389/fnagi.2014.00252. eCollection 2014.
10
Single neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.与早期阿尔茨海默病认知衰退率相关的单一神经心理学测试分数
Clin Neuropsychol. 2014;28(6):926-40. doi: 10.1080/13854046.2014.944937. Epub 2014 Aug 18.